Gate Pass Capital, LLC Inmune Bio, Inc. Transaction History

Gate Pass Capital, LLC

  • $173 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Sep 22, 2025
SELL
$2.31 - $8.26 $542,850 - $1.94 Million
-235,000 Closed
0 $0
Q1 2025

Sep 22, 2025
BUY
$4.93 - $10.48 $394,400 - $838,400
80,000 Added 51.61%
235,000 $1.84 Billion
Q4 2024

Sep 22, 2025
BUY
$4.4 - $6.43 $682,000 - $996,650
155,000 New
155,000 $724 Million

Others Institutions Holding INMB

# of Institutions
85
Shares Held
5.36M
Call Options Held
310K
Put Options Held
371K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $26M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Gate Pass Capital, LLC Portfolio

Follow Gate Pass Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gate Pass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gate Pass Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email